Effective management of pelvic lymphocysts by laparoscopic marsupialization.

F. O. Recio, Sharad A Ghamande, R. E. Hempling, M. S. Piver

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND AND OBJECTIVES: To evaluate laparoscopic transperitoneal marsupialization of pelvic lymphocysts at the time of laparoscopically directed assessment of response to first-line therapy in a population of patients treated for International Federation of Gynecologists and Obstetricians (FIGO) stage IC-IIC epithelial ovarian cancer. METHODS: Between March 1995 and March 1998, eight patients with FIGO stage IC-IIC serous epithelial ovarian tumors who developed pelvic lymphocysts after primary surgical staging underwent transperitoneal laparoscopically directed marsupialization of lymphocysts at the time of second-look laparoscopy. RESULTS: The mean age of the patient population was 50 years (range 23-65 years). The mean length of time required for marsupialization was 30 minutes (range 25-35 minutes). No patient required inpatient postoperative care. No intraoperative complications were observed. Computerized axial tomography (CT) scan of the abdomen and pelvis obtained 12 weeks following surgery failed to demonstrate re-accumulation of lymphocysts among any patient in the study population. With a median follow-up of 20 months (range 3-39 months), no patients have demonstrated pelvic lymphocyst recurrence. CONCLUSIONS AND DISCUSSION: Laparoscopically directed marsupialization of pelvic lymphocysts is technically feasible, safe and effective. Further study of this technique appears to be warranted.

Original languageEnglish (US)
Pages (from-to)97-102
Number of pages6
JournalJSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons
Volume3
Issue number2
StatePublished - Jan 1 1999
Externally publishedYes

Fingerprint

Population
Postoperative Care
Intraoperative Complications
Pelvis
Abdomen
Laparoscopy
Inpatients
Tomography
Recurrence
Neoplasms
Therapeutics
Ovarian epithelial cancer

ASJC Scopus subject areas

  • Surgery

Cite this

Effective management of pelvic lymphocysts by laparoscopic marsupialization. / Recio, F. O.; Ghamande, Sharad A; Hempling, R. E.; Piver, M. S.

In: JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons, Vol. 3, No. 2, 01.01.1999, p. 97-102.

Research output: Contribution to journalArticle

@article{7d3d423c890f4308bc2e36b8a9f3a304,
title = "Effective management of pelvic lymphocysts by laparoscopic marsupialization.",
abstract = "BACKGROUND AND OBJECTIVES: To evaluate laparoscopic transperitoneal marsupialization of pelvic lymphocysts at the time of laparoscopically directed assessment of response to first-line therapy in a population of patients treated for International Federation of Gynecologists and Obstetricians (FIGO) stage IC-IIC epithelial ovarian cancer. METHODS: Between March 1995 and March 1998, eight patients with FIGO stage IC-IIC serous epithelial ovarian tumors who developed pelvic lymphocysts after primary surgical staging underwent transperitoneal laparoscopically directed marsupialization of lymphocysts at the time of second-look laparoscopy. RESULTS: The mean age of the patient population was 50 years (range 23-65 years). The mean length of time required for marsupialization was 30 minutes (range 25-35 minutes). No patient required inpatient postoperative care. No intraoperative complications were observed. Computerized axial tomography (CT) scan of the abdomen and pelvis obtained 12 weeks following surgery failed to demonstrate re-accumulation of lymphocysts among any patient in the study population. With a median follow-up of 20 months (range 3-39 months), no patients have demonstrated pelvic lymphocyst recurrence. CONCLUSIONS AND DISCUSSION: Laparoscopically directed marsupialization of pelvic lymphocysts is technically feasible, safe and effective. Further study of this technique appears to be warranted.",
author = "Recio, {F. O.} and Ghamande, {Sharad A} and Hempling, {R. E.} and Piver, {M. S.}",
year = "1999",
month = "1",
day = "1",
language = "English (US)",
volume = "3",
pages = "97--102",
journal = "Journal of the Society of Laparoendoscopic Surgeons",
issn = "1086-8089",
publisher = "Society of Laparoendoscopic Surgeons",
number = "2",

}

TY - JOUR

T1 - Effective management of pelvic lymphocysts by laparoscopic marsupialization.

AU - Recio, F. O.

AU - Ghamande, Sharad A

AU - Hempling, R. E.

AU - Piver, M. S.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - BACKGROUND AND OBJECTIVES: To evaluate laparoscopic transperitoneal marsupialization of pelvic lymphocysts at the time of laparoscopically directed assessment of response to first-line therapy in a population of patients treated for International Federation of Gynecologists and Obstetricians (FIGO) stage IC-IIC epithelial ovarian cancer. METHODS: Between March 1995 and March 1998, eight patients with FIGO stage IC-IIC serous epithelial ovarian tumors who developed pelvic lymphocysts after primary surgical staging underwent transperitoneal laparoscopically directed marsupialization of lymphocysts at the time of second-look laparoscopy. RESULTS: The mean age of the patient population was 50 years (range 23-65 years). The mean length of time required for marsupialization was 30 minutes (range 25-35 minutes). No patient required inpatient postoperative care. No intraoperative complications were observed. Computerized axial tomography (CT) scan of the abdomen and pelvis obtained 12 weeks following surgery failed to demonstrate re-accumulation of lymphocysts among any patient in the study population. With a median follow-up of 20 months (range 3-39 months), no patients have demonstrated pelvic lymphocyst recurrence. CONCLUSIONS AND DISCUSSION: Laparoscopically directed marsupialization of pelvic lymphocysts is technically feasible, safe and effective. Further study of this technique appears to be warranted.

AB - BACKGROUND AND OBJECTIVES: To evaluate laparoscopic transperitoneal marsupialization of pelvic lymphocysts at the time of laparoscopically directed assessment of response to first-line therapy in a population of patients treated for International Federation of Gynecologists and Obstetricians (FIGO) stage IC-IIC epithelial ovarian cancer. METHODS: Between March 1995 and March 1998, eight patients with FIGO stage IC-IIC serous epithelial ovarian tumors who developed pelvic lymphocysts after primary surgical staging underwent transperitoneal laparoscopically directed marsupialization of lymphocysts at the time of second-look laparoscopy. RESULTS: The mean age of the patient population was 50 years (range 23-65 years). The mean length of time required for marsupialization was 30 minutes (range 25-35 minutes). No patient required inpatient postoperative care. No intraoperative complications were observed. Computerized axial tomography (CT) scan of the abdomen and pelvis obtained 12 weeks following surgery failed to demonstrate re-accumulation of lymphocysts among any patient in the study population. With a median follow-up of 20 months (range 3-39 months), no patients have demonstrated pelvic lymphocyst recurrence. CONCLUSIONS AND DISCUSSION: Laparoscopically directed marsupialization of pelvic lymphocysts is technically feasible, safe and effective. Further study of this technique appears to be warranted.

UR - http://www.scopus.com/inward/record.url?scp=0033109928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033109928&partnerID=8YFLogxK

M3 - Article

C2 - 10444006

AN - SCOPUS:0033109928

VL - 3

SP - 97

EP - 102

JO - Journal of the Society of Laparoendoscopic Surgeons

JF - Journal of the Society of Laparoendoscopic Surgeons

SN - 1086-8089

IS - 2

ER -